Tikosyn® (dofetilide) 500 mcg (0.5mg) capsules, 60-count bottle, Rx only Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, NDC 00069-5820-60
Published April 30, 2014 · Recall initiated: April 8, 2014
Summary
FDA records drug Class II recall D-1253-2014, published April 30, 2014 and initiated April 8, 2014. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 23,064 bottles; Lot: H48496, H48497; Exp 05/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foriegn Tablets/Capsules: A single Tikosyn® (dofetilide) 250 mcg capsule was discovered in one bottle of Tikosyn® (dofetilide) 500 mcg (0.5 mg).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pfizer Inc.
- Distributor
- US Nationwide including Puerto Rico and US Virgin Islands. 65 federal government accounts received the affected product directly from Pfizer Inc
- Lot
- H48496, H48497; Exp 05/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- US
Related recalls
- FDABicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only,August 6, 2025
- FDABicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only,August 6, 2025
- FDADOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials,July 2, 2025
- FDALabetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile CartridgeJuly 3, 2024
- FDAGlycopyrrolate (MDV) 0.2 MG/ML Injectable, 5 mL Vials, Sterile Serum Vials/Sterile Syringes, for use by aApril 30, 2014
- FDADay Time Cold & Flu, Multi-Symptom, Non-Drowsy, Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, 4, 6,April 30, 2014
Questions about this recall
Was Tikosyn® (dofetilide) 500 mcg (0.5mg) capsules, 60-count bottle, Rx only Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, NDC 00069-5820-60 recalled?
Yes. FDA published recall D-1253-2014 on April 30, 2014. Reported hazard: Presence of Foriegn Tablets/Capsules: A single Tikosyn® (dofetilide) 250 mcg capsule was discovered in one bottle of Tikosyn® (dofetilide) 500 mcg (0.5 mg).
What should I do if I have this product?
Voluntary: Firm initiated · Letter